Celltrion
068270.KS
#808
Rank
$24.53 B
Marketcap
$118.48
Share price
0.73%
Change (1 day)
-0.29%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of March 2024 : $1.61 Billion USD

According to Celltrion 's latest financial reports the company's total debt is $1.61 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31$0.62 B0.45%
2021-12-31$0.62 B-12.24%
2020-12-31$0.71 B66.39%
2019-12-31$0.42 B-7.42%
2018-12-31$0.46 B-23.03%
2017-12-31$0.60 B6.74%
2016-12-31$0.56 B-16.81%
2015-12-31$0.67 B-12.28%
2014-12-31$0.77 B8.59%
2013-12-31$0.71 B23.19%
2012-12-31$0.57 B60.49%
2011-12-31$0.35 B47.37%
2010-12-31$0.24 B12.95%
2009-12-31$0.21 B15.69%
2008-12-31$0.18 B534.4%
2007-12-31$29.43 M